EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+11.07%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.1B
AUM Growth
-$1.95B
(-64%)
Cap. Flow
-$2.1B
Cap. Flow
% of AUM
-190.3%
Top 10 Holdings %
Top 10 Hldgs %
55.43%
Holding
359
New
34
Increased
188
Reduced
93
Closed
36
Top Buys
| 1 |
STAAR Surgical
STAA
|
$42.6M |
| 2 |
Sea Limited
SE
|
$22.9M |
| 3 |
Mercado Libre
MELI
|
$19.7M |
| 4 |
NIO
NIO
|
$19.6M |
| 5 |
Meta Platforms (Facebook)
META
|
$16.1M |
Top Sells
| 1 |
Alibaba
BABA
|
$1.32B |
| 2 |
JD.com
JD
|
$334M |
| 3 |
Baidu
BIDU
|
$314M |
| 4 |
NetEase
NTES
|
$202M |
| 5 |
Trip.com Group
TCOM
|
$95M |
Sector Composition
| 1 | Consumer Discretionary | 35.58% |
| 2 | Technology | 17.59% |
| 3 | Communication Services | 16.9% |
| 4 | Healthcare | 11.23% |
| 5 | Real Estate | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Revolution Medicines
RVMD
$7.57B
| $230K | 0.02% |
+11,805
| New | +$230K |
|
277
Lowe's Companies
LOW
$151B
| $229K | 0.02% |
1,313
-38
| -3% | -$6.63K |
|
278
Myriad Genetics
MYGN
$615M
| $227K | 0.02% |
+12,481
| New | +$227K |
|
279
CDW
CDW
$22.2B
| $224K | 0.02% |
1,420
-21
| -1% | -$3.31K |
|
280
Stryker
SYK
$150B
| $224K | 0.02% |
1,124
+35
| +3% | +$6.98K |
|
|
CERE
281
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $224K | 0.02% |
+8,484
| New | +$224K |
|
282
Arista Networks
ANET
$180B
| $222K | 0.02% |
9,468
+32
| +0.3% | +$750 |
|
283
Humana
HUM
$37B
| $222K | 0.02% |
474
-30
| -6% | -$14.1K |
|
284
Regenxbio
RGNX
$490M
| $221K | 0.02% |
+8,967
| New | +$221K |
|
|
AGEN
285
Agenus
AGEN
$138M
| $219K | 0.02% |
5,749
+2,765
| +93% | +$105K |
|
286
Edwards Lifesciences
EW
$47.5B
| $218K | 0.02% |
2,297
+39
| +2% | +$3.7K |
|
287
Xencor
XNCR
$610M
| $217K | 0.02% |
+7,917
| New | +$217K |
|
288
Arcturus Therapeutics
ARCT
$485M
| $216K | 0.02% |
13,735
+1,825
| +15% | +$28.7K |
|
289
Constellation Energy
CEG
$94.2B
| $216K | 0.02% |
3,765
+43
| +1% | +$2.47K |
|
290
Royal Caribbean
RCL
$95.7B
| $216K | 0.02% |
6,175
+2,787
| +82% | +$97.5K |
|
|
VXRT
291
DELISTED
Vaxart
VXRT
| $216K | 0.02% |
61,614
+11,625
| +23% | +$40.8K |
|
|
CDMO
292
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $214K | 0.02% |
13,994
+3,159
| +29% | +$48.3K |
|
293
Morgan Stanley
MS
$236B
| $211K | 0.02% |
2,779
-21
| -0.8% | -$1.59K |
|
294
Gartner
IT
$18.6B
| $206K | 0.02% |
850
-25
| -3% | -$6.06K |
|
295
Boston Scientific
BSX
$159B
| $205K | 0.02% |
5,493
+134
| +3% | +$5K |
|
296
Centene
CNC
$14.2B
| $203K | 0.02% |
2,401
-27
| -1% | -$2.28K |
|
297
Goldman Sachs
GS
$223B
| $203K | 0.02% |
682
+19
| +3% | +$5.66K |
|
298
Lockheed Martin
LMT
$108B
| $203K | 0.02% |
471
-8
| -2% | -$3.45K |
|
299
Zscaler
ZS
$42.7B
| $201K | 0.02% |
1,347
+31
| +2% | +$4.63K |
|
|
MORF
300
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $201K | 0.02% |
+9,266
| New | +$201K |
|